Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, is partnering with Saama Technologies, a leading clinical data analytics company, to improve awareness of, access to, and participation in clinical trials for U.S. physicians and patients.

“We are excited to work with Saama to develop an innovative technology platform to transform the clinical research process overall, from standards-based data collection to eSubmissions to regulatory agencies,” said John Potthoff, Ph.D., Elligo chief executive officer.

Through its Goes Direct model, Elligo engages physicians and their patients by first identifying patients using electronic health records and then providing their physicians with the infrastructure to conduct the research in their own offices at no cost to them. Saama’s Life Science Analytics Cloud, powered by its unique, AI-enabled Fluid Analytics Engine, includes the Cohort Builder and Trial Planning Optimizer solutions, which facilitate the identification of patient populations based on clinical trial eligibility requirements.

Suresh Katta, founder and chief executive officer of Saama, said, “Together, Saama and Elligo will set a new bar for physician and patient access to, and engagement with, clinical research that may improve patients’ health, enhance physicians’ understanding of disease management, and expand medical knowledge for treating some of the most prevalent and devastating human diseases.”

The partnership will help resolve the challenges sponsors face when they must assemble vast amounts of data from disparate sources.